Changes in Neurocognitive Function in Patients With Schizophrenia After Starting or Switching to Amisulpride in Comparison With the Normal Controls-Reference-Cited by-同舟云学术

Changes in Neurocognitive Function in Patients With Schizophrenia After Starting or Switching to Amisulpride in Comparison With the Normal Controls

Published:2009-04 Issue:2 Volume:29 Page:117-123
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Ahn Yong Min,Lee Kyu Young,Kim Chul-Eung,Kim Jae-Jin,Kang Dae-Yeob,Jun Tae-Youn,Choi Jin Sook,Chung In-Won,Kim Se Hyun,Hwang Samuel S.-H.,Kim Yong Sik

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference28 articles.

1. The effects of second generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.;Weiss;Psychopharmacology,2002

2. Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?;Tyson;Int J Neurosci,2004

3. Cognitive function and social abilities in patients with schizophrenia: relationship with atypical antipsychotics.;Tyson;Psychiatry Clin Neurosci,2006

4. Risperidone in the treatment of schizophrenia.;Marder;Am J Psychiatry,1994

5. A meta-analysis of the efficacy of second-generation antipsychotics.;Davis;Arch Gen Psychiatry,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses;Frontiers in Psychiatry;2022-03-17

2. Neurocognitive Benefits of Second-Generation Antipsychotics Versus Placebo;Journal of Clinical Psychopharmacology;2017-04

3. Effects of aripiprazole and haloperidol on neural activation during a simple motor task in healthy individuals: A functional MRI study;Human Brain Mapping;2016-12-23

4. Neurocognitive functioning as an intermediary variable between psychopathology and insight in schizophrenia;Psychiatry Research;2015-12

5. Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement;Pharmacology Biochemistry and Behavior;2015-11